title: Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.
authors.forename: Richard E
authors.initials: RE
authors.lastname: Chaisson
authors.forename: Joan
authors.initials: J
authors.lastname: Armstrong
authors.forename: John
authors.initials: J
authors.lastname: Stafford
authors.forename: Jonathan
authors.initials: J
authors.lastname: Golub
authors.forename: Sarah
authors.initials: S
authors.lastname: Bur
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008396:Maryland; D011329:Prisoners; D011718:Pyrazinamide / Q000008:administration & dosage / Q000627:therapeutic use*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin